
Paxlovid, a medication that has helped millions of high-risk COVID patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Administration on Thursday. An FDA advisory panel voted 16-1 that the Pfizer drug remains a safe and effective treatment and should be given… read on > read on >